Dynavax Technologies Corp. DVAX

NAS: DVAX | ISIN: US2681582019 12/09/2025

9,410 USD (-3,39%)

(-3,39%) 12/09/2025

Grafiek Dynavax Technologies Corp.

Grafiek Dynavax Technologies Corp.

1 dag1d -3,39%
1 week1w -2,99%
1 maand1m -12,79%
3 maanden3m -7,47%
6 maanden6m -30,96%
1 jaar1j -15,61%
5 jaar5j 75,89%

Dynavax Technologies Corp. in het nieuws

Toon enkel gratis nieuws

27 augustus 2025 · Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference · Persbericht

21 augustus 2025 · Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile · Persbericht

7 augustus 2025 · Dynavax Reports Second Quarter 2025 Financial Results · Persbericht

29 juli 2025 · Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025 · Persbericht

11 juni 2025 · Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting · Persbericht

9 juni 2025 · Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting · Persbericht

4 juni 2025 · Dynavax Comments on Glass Lewis Recommendation · Persbericht

28 mei 2025 · Dynavax to Present at William Blair's 45th Annual Growth Stock Conference · Persbericht

23 mei 2025 · Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees · Persbericht

12 mei 2025 · Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value · Persbericht

Profiel Dynavax Technologies Corp.

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Website: www.dynavax.com

Hoofdzetel: Emeryville, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe